Page 8 - Valuating News Today

By Chris Wack Praxis Precision Medicines Inc. said Friday that topline results from its Phase 2 study evaluating the efficacy, safety and tolerability of ulixacaltamide for the treatment of... | March 3, 2023

With this strategic effort, HARMAN is tapping into ACM's real-world driving environments equipped with connected infrastructure and Multi-access Edge Computing (MEC) services for evaluating road-ready

BALTIMORE, MD / ACCESSWIRE / February 28, 2023 / Tiderock Companies, Inc. ("we", "our", or the "Company"), (OTC PINK:TDRK) is seeking to find opportunities within Solar Industry and Green Energy that can

Presentations on Additional REDUCE-IT® Sub-Population, In-Vitro Data on EPA to Be Featured at the CongressDUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc

NEW YORK, Feb. 24, 2023 /PRNewswire/ -- As per Zion Market Research study, The global mashed potatoes industry size was nearly $9.1 Billion in 2022 and is set to reach $16.1 Billion by 2030

First vaccine to target dendritic cells, key activators of the immune system Novel delivery of the HIV envelope protein potentially critical to future vaccine strategies Safe and able

New York & Saint-Herblain (France), February 17, 2023 - Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announce that Pfizer, as the study sponsor, has decided to discontinue

Highly compelling, statistically significant, clinically meaningful improvement in assessments of symptoms of psychosis, disease severity and global evaluation at one year;increase in magnitude of

Teck Resources Ltd on Thursday confirmed that it was evaluating options for its steelmaking coal business, including a possible spinoff.... | February 16, 2023

- Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with toripalimab plus chemotherapy significantly prolongs survival in patients with advanced NPC - SHANGHAI, China